Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 7,501–7,560 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

St Michael’s Hospice1 St Richard’s Hospice1 St Thomas' NHS Foundation Trust1 St Thomas’ Medical School1 St Vincent Charity Medical Center1 St Vincent’s Hospice1 St Vincent’s Hospital Headache Clinic1 St-Etienne University Hospital1 St. Catharines Site1 St. George’s Hospital Endoscopy unit1 St. James’s Place Charitable Foundation1 St. John’s Medical College & Research Institute1 St. Joseph’s Children’s Hospital1 St. Joseph’s Hospital1 St. Jude1 St. Luke’s Hospital Kilkenny1 St. Luke’s Medical Center Global City1 St. Luke’s Medical Center – Global City1 St. Luke’s Medical Center-Global City1 St. Maarten Medical Center1 St. Mary’s Hospital Lacor1 St. Michael’s Hospital1 St. Olavs University Hospital1 St. Paul’s Hospital1 St. Paul’s Hospital Millennium Medical College1 St. Petersburg1 St. Pölten University of Applied Sciences1 St. Vincent’s Hospice1 St. Vincent’s Hospital Group1 St. Vincent’s Private Hospital1 Stanford Design Thinking School1 Stanford Health Care31 Stanford University Institutional Review Board1 Starship Children’s Hospital1 Starzl et al.1 StatPearls1 State Education Research and Partnerships1 State Unintentional Drug Overdose Reporting System1 State University of Campinas1 Statistical Office of Serbia1 Statistics Canada1 Stemcell Technologies1 Steno Diabetes Centers1 Stephen Reicher1 Stephens et al1 Stephenson Cancer Center1 Stepping Stones1 Sterling IRB1 Steve Biko Academic Hospital1 Stifani and Lavelanet1 Stockport Scientific1 Stojanovski et al1 Stonewall UK1 Stony Brook University Hospital1 Strathmore University1 Stroke Code Registry of Catalonia1 Stroke Unit1 Study I1 Study II1 Study III1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 226 of 946

P.168 Prevalence and risk factors for oesophageal strictures in systemic sclerosis

jsrd · abstract · 2026-06-05 · 2 matching annotations

83.2%

Australian Scleroderma Cohort study ASCS Proton pump inhibitors Gastro-oesophageal reflux disease (GORD)SSc-OS systemic sclerosis PPIs SSc

…ated with OS.Material and Methods Consecutive patients from the Australian Scleroderma Cohort study (ASCS) who met ACR/EULAR criteria for SSc were included. OS was…

P.180 Self-reported oropharyngeal dysphagia and swallowing-related quality of life in people with systemic sclerosis: preliminary results of a cross-sectional study

jsrd · abstract · 2026-06-05 · 2 matching annotations

88.6%

Marche University Hospital Scleroderma Unit proton pump inhibitors systemic sclerosis SSc

…secutive SSc patients were recruited by the Scleroderma Unit of Marche University Hospital, Ancona, Italy. Every participant completed the Italian version…

P.194 Raynaud’s phenomenon in the setting of immune checkpoint inhibitors: a case series and possible implications

jsrd · abstract · 2026-06-05 · 2 matching annotations

90.1%

cancer center rheumatology systemic sclerosis Raynaud’s phenomenon (RP)

…erienced ICI-induced RP and were evaluated by rheumatology at a cancer center within the past 3 years where their cancers, type of ICIs, diag…

P.196 Clinical and laboratory associations of TNF-alfa in patients with systemic scleroderma

jsrd · abstract · 2026-06-05 · 2 matching annotations

89.1%

MSCT Systemic sclerosis (SSc)pulmonary arterial hypertension rituximab pulmonary fibrosis TNF-alfa TNF-alfa inhibitors

…f SSc.Material and Methods 66 patients with SSc-ILD verified by MSCT were enrolled into the study (disease duration 7.2±5.6 years, d…

P.212 From normal to active scleroderma pattern: nailfold videocapillaroscopy as a mirror of disease progression in systemic sclerosis

jsrd · abstract · 2026-06-05 · 2 matching annotations

84.6%

Rheumatology Systemic sclerosis (SSc)methotrexate rituximab vasodilator therapy

…Material and Methods A case report of a patient followed at our Rheumatology clinic.Results A 62-year-old man was referred to Rheumatology f…

P.213 Comparison of localized scleroderma assessment tools, teletermography and ultrasound in the evaluation of juvenile localized cutaneous scleroderma: preliminary data of a monocentric study

jsrd · abstract · 2026-06-05 · 2 matching annotations

92.6%

Gaslini Hospital Rheumatology Unit mophetil micofenolate MTX methotrexate Juvenile Localized cutaneous scleroderma (JLS)

…d Methods JLS patients followed at the Rheumatology Unit of the Gaslini Hospital were evaluated retro-prospectively. Patients were diagnosed acc…

P.216 Immunosuppressive drug use in limited systemic sclerosis: an international survey

jsrd · abstract · 2026-06-05 · 2 matching annotations

92.6%

Canadian Scleroderma Research Group Scleroderma Clinical Trials Consortium mycophenolate mofetil hydroxychloroquine methotrexate lcSSc interstitial lung disease diffuse cutaneous systemic sclerosis myositis myocarditis+1 more

… in Quebec and Canada, as well as SSc experts affiliated to the Canadian Scleroderma Research Group and the Scleroderma Clinical Trials Consortium. Questions were …

P.224 Metabolomic and lipidomic profiling in patients with systemic sclerosis

jsrd · abstract · 2026-06-05 · 2 matching annotations

88.3%

Sahlgrenska University Hospital Swedish Metabolomics Center Systemic Sclerosis theophylline caffeine systemic sclerosis (SSc)anti-rheumatic treatment interstitial lung disease (ILD)SSc

…oject (WESST) is a longitudinal cohort study of SSc patients at Sahlgrenska University Hospital, Gothenburg, Sweden, and healthy controls. All patients met the…

P.259 Advancing drug development for systemic sclerosis by prioritising findings from human genetic association studies

jsrd · abstract · 2026-06-05 · 2 matching annotations

79.4%

CONQUEST Amlitelimab SSc systemic sclerosis

…(anti-OX40L monoclonal antibody) is currently being explored in CONQUEST, a multicentre randomised controlled platform trial for SSc-ILD…

P.268 Efficacy and safety results from a phase 2B trial of fipaxalparant in patients with diffuse cutaneous systemic sclerosis

jsrd · abstract · 2026-06-05 · 2 matching annotations

87.5%

NCT04781543 BEACON fipaxalparant Health Assessment Questionnaire

…ized controlled trial of fipaxalparant in patients with dcSSc ( NCT04781543).Material and Methods Eligible adults =/< 75 years met the 2013…

P.273 Sharp debridement of digital ulcer in systemic sclerosis (shed SSc): a multicenter randomised control trial feasibility study

jsrd · abstract · 2026-06-05 · 2 matching annotations

93.3%

Leeds Teaching Hospitals Royal Free London NHS Trusts systemic sclerosis (SSc)Sharp debridement SSc topical anaesthesia standard wound care Digital ulcers (DUs)

…rial and Methods An open-label feasibility RCT was conducted at Leeds Teaching Hospitals and Royal Free London NHS Trusts. Adults with SSc and active DU…

P.313 Hand function impairment in systemic sclerosis: determinants through investigations of clinical, radiographic and ultrasonographic features

jsrd · abstract · 2026-06-05 · 2 matching annotations

81.9%

Rennes Validation Cohort Paris-Pavia Cohort Systemic Sclerosis

…) were enrolled (73 from the Paris-Pavia Cohort and 67 from the Rennes Validation Cohort). Median (IQR) CHFS score was 6 [1.5; 20.5] in the original coh…